These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23990470)

  • 81. Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other.
    Litvinov RI; Yakovlev S; Tsurupa G; Gorkun OV; Medved L; Weisel JW
    Biochemistry; 2007 Aug; 46(31):9133-42. PubMed ID: 17630702
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Mast cell restricted mouse and human tryptase·heparin complexes hinder thrombin-induced coagulation of plasma and the generation of fibrin by proteolytically destroying fibrinogen.
    Prieto-García A; Zheng D; Adachi R; Xing W; Lane WS; Chung K; Anderson P; Hansbro PM; Castells M; Stevens RL
    J Biol Chem; 2012 Mar; 287(11):7834-44. PubMed ID: 22235124
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Antithrombin binding of low molecular weight heparins and inhibition of factor Xa.
    Lin P; Sinha U; Betz A
    Biochim Biophys Acta; 2001 Apr; 1526(1):105-13. PubMed ID: 11287128
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
    von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1996 Sep; 76(3):347-53. PubMed ID: 8883269
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Interaction of heparin with synthetic antithrombin III peptide analogues.
    Bae J; Desai UR; Pervin A; Caldwell EE; Weiler JM; Linhardt RJ
    Biochem J; 1994 Jul; 301 ( Pt 1)(Pt 1):121-9. PubMed ID: 8037658
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The receptor for the globular "heads" of C1q, gC1q-R, binds to fibrinogen/fibrin and impairs its polymerization.
    Lu PD; Galanakis DK; Ghebrehiwet B; Peerschke EI
    Clin Immunol; 1999 Mar; 90(3):360-7. PubMed ID: 10075865
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Controlled preparation of thin fibrin films immobilized at solid surfaces.
    Riedel T; Brynda E; Dyr JE; Houska M
    J Biomed Mater Res A; 2009 Feb; 88(2):437-47. PubMed ID: 18306296
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The structure and biological features of fibrinogen and fibrin.
    Mosesson MW; Siebenlist KR; Meh DA
    Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The procoagulant effect of zinc on fibrin clot formation.
    Marx G; Eldor A
    Am J Hematol; 1985 Jun; 19(2):151-9. PubMed ID: 4003387
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats.
    Schoots IG; Levi M; van Vliet AK; Maas AM; Roossink EH; van Gulik TM
    Crit Care Med; 2004 Jun; 32(6):1375-83. PubMed ID: 15187522
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Characterization of the conformational alterations, reduced anticoagulant activity, and enhanced antiangiogenic activity of prelatent antithrombin.
    Richard B; Swanson R; Schedin-Weiss S; Ramirez B; Izaguirre G; Gettins PG; Olson ST
    J Biol Chem; 2008 May; 283(21):14417-29. PubMed ID: 18375953
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.
    Weitz JI; Leslie B; Hudoba M
    Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Surface plasmon resonance spectroscopy study of interfacial binding of thrombin to antithrombin DNA aptamers.
    Tang Q; Su X; Loh KP
    J Colloid Interface Sci; 2007 Nov; 315(1):99-106. PubMed ID: 17689549
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Characterization of assembly, product formation, and heparin dissociation steps in the factor Xa reaction.
    Craig PA; Olson ST; Shore JD
    J Biol Chem; 1989 Apr; 264(10):5452-61. PubMed ID: 2925612
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Zinc ions promote the interaction between heparin and heparin cofactor II.
    Eckert R; Ragg H
    FEBS Lett; 2003 Apr; 541(1-3):121-5. PubMed ID: 12706831
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa.
    Glauser BF; Rezende RM; Melo FR; Pereira MS; Francischetti IM; Monteiro RQ; Rezaie AR; Mourão PA
    Thromb Haemost; 2009 Dec; 102(6):1183-93. PubMed ID: 19967150
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Mutation of the H-helix in antithrombin decreases heparin stimulation of protease inhibition.
    Gonzales PR; Walston TD; Camacho LO; Kielar DM; Church FC; Rezaie AR; Cooper ST
    Biochim Biophys Acta; 2007 Nov; 1774(11):1431-7. PubMed ID: 17905675
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.
    Huntington JA; Gettins PG
    Biochemistry; 1998 Mar; 37(10):3272-7. PubMed ID: 9521646
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The Story of the Fibrin(ogen) αC-Domains: Evolution of Our View on Their Structure and Interactions.
    Medved L; Weisel JW
    Thromb Haemost; 2022 Aug; 122(8):1265-1278. PubMed ID: 34902868
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix.
    Martino MM; Briquez PS; Ranga A; Lutolf MP; Hubbell JA
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4563-8. PubMed ID: 23487783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.